Spanish scientists from the Banc de Sang i Teixits (BST) de Catalunya and the Institut d’Investigació Biomèdica de Bellvitge (Idibell) have signed an agreement to carry out research into the genetic modification of stem cells from umbilical cord blood.
Once again, stem cells obtained from umbilical cord blood are promising for the future of health, as well as being a fascinating field of research in medical science.
These cells, present in the umbilical cord blood of newborns, are remarkable for their capacity for self-renewal and their potential to differentiate into a variety of specialized cell types.
Their ability to form blood cells, such as red blood cells, white blood cells and platelets, is especially valuable for the treatment of various hematological diseases and genetic disorders.
Umbilical cord stem cells have proven to be a rich source of hematopoietic stem cells, which have been successfully used in bone marrow transplants to treat conditions such as leukemia and other blood cancers.
In addition, these cells possess unique immunomodulatory characteristics, which can contribute to the regeneration and repair of damaged tissues in various autoimmune diseases. An expert in this research explains: “We believe that our development will make it possible to produce immune system cells designed to attack specific therapeutic targets in a much faster, more effective and cheaper way than technologies currently being tested. Our system can also be applied to other diseases, such as fungal infections or those caused by antibiotic-resistant bacteria,” explained Daniel Bachiller, from the CIB. Read more about this news
You may be interested in
Introduction Post-surgical inflammation constitutes an essential physiological response to tissue injury, playing a critical role in activating repair and regeneration processes. This process is characterized by a complex interaction between
Medicine is rapidly evolving toward increasingly precise, less invasive approaches focused on addressing the root causes of disease. In this context, the integration of regenerative medicine with advanced technologies such
Life is demanding. Day-to-day life is often marked by schedules, plans, goals, obligations… pure activity. We need to move. On the other hand, WHO recommendations are very clear: physical activity
A biological treasure, a miracle of life, an extraordinary reality… These are some of the adjectives that the scientific world has dedicated to hematopoietic stem cells in recent years. It
The potential of regenerative medicine to improve the quality of life in chronic degenerative diseases continues to grow. In this case, we will learn about its ability to slow down
This news is a reality! For the first time in history a woman is cured 100% of HIV, since 2017 until today she is totally healthy, thanks to umbilical cord
Regenerative medicine: One of the most common diseases is osteoarthritis of the knee, the most prevalent joint disease, which causes joint pain, functional loss and disability. Thanks to current research,
Every day we wake up to encouraging news about the use of exosomes for sports injuries. From the most common to the most complex. Regenerative biomedicine is advancing, and strongly,
